Digital Biomarkers in Movement Disorders

How digital biomarkers in clinical studies can determine the best treatments for patients.

Download our white paper to learn more.

Clinical studies using digital biomarkers can potentially be designed to have ample statistical power with fewer patients. The Clinical ink Watch-PD study demonstrated that digital biomarkers can detect the presence of Parkinson’s disease through wearable devices by collecting data on motor symptoms, activities of daily living, and other disease-related factors. Our study also explored the potential of digital biomarkers in predicting disease severity and progression in ALS patients. Perhaps most importantly the study proved that treatment response in PD can be detected, a finding with immediate applications in clinical trials of disease-modifying agents. 

Digital biomarkers may provide valuable insights into disease progression and help clinicians develop more personalized treatment plans. 

Download this white paper to learn more.

Scroll to Top